- Q2 2023 OpGen Inc Earnings Call TranscriptAug 10, 2023$3.38 (-23.42%)Earnings
- Q1 2023 OpGen Inc Earnings Call TranscriptMay 15, 2023$7 (-6.91%)Earnings
- Q4 2022 OpGen Inc Earnings Call TranscriptMar 29, 2023$13.6 (-6.85%)Earnings
- Q3 2022 OpGen Inc Earnings Call TranscriptNov 10, 2022$37 (+4.17%)Earnings
- Q2 2022 OpGen Inc Earnings Call TranscriptAug 11, 2022$126 (+5.00%)Earnings
- Q1 2022 OpGen Inc Earnings Call TranscriptMay 12, 2022$71.52 (+12.52%)Earnings
- Q4 2021 OpGen Inc Earnings Call TranscriptMar 29, 2022$170 (+10.68%)Earnings
- Q3 2021 OpGen Inc Earnings Call TranscriptNov 11, 2021$340Earnings
- Q2 2021 OpGen Inc Earnings Call TranscriptAug 12, 2021$508 (-7.30%)Earnings
- Q1 2021 OpGen Inc Earnings Call TranscriptMay 13, 2021$398 (-11.56%)Earnings
- Q4 2020 OpGen Inc Earnings Call TranscriptMar 25, 2021$540 (-0.74%)Earnings
- Q3 2020 OpGen Inc Earnings Call TranscriptNov 11, 2020$458 (+7.01%)Earnings
- Q2 2020 OpGen Inc Earnings Call TranscriptAug 12, 2020$522 (+1.95%)Earnings
- Q1 2020 OpGen Inc Earnings Call TranscriptMay 07, 2020$448 (-0.44%)Earnings
- Q4 2019 OpGen Inc Earnings Call TranscriptMar 24, 2020$598 (-4.47%)Earnings
- Q3 2019 OpGen Inc Earnings Call TranscriptNov 06, 2019$264 (+3.94%)Earnings
- OpGen Inc and Curetis NV Enter Into Definitive Agreement to Combine Businesses - M&A Call TranscriptSep 04, 2019
- Q2 2019 OpGen Inc Earnings Call TranscriptAug 07, 2019$1300 (+4.57%)Earnings
- Q1 2019 OpGen Inc Earnings Call TranscriptMay 14, 2019$1720 (-11.52%)Earnings
- Q4 2018 OpGen Inc Earnings Call TranscriptFeb 26, 2019$5760 (-4.00%)Earnings
Q2 2019 OpGen Inc Earnings Call Transcript
Welcome to the OpGen Second Quarter 2019 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded today, August 7, 2019. Thank you all for participating in today's call.
Before we begin, I would like to caution that comments made during this conference call by management will contain forward-looking statements regarding the operations and future results of OpGen. I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent forms 10-K and 10-Q, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Factors that may affect the company's results include, but are not limited to, its ability to successfully complete the demonstration project with New York State; successfully, timely and cost effectively seek and obtain regulatory clearance for and commercialize its product and service offerings; the rate of adoption of its products and services by hospitals and other healthcare
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)